Search
for
Sort by
Research 151–180 of 1000+
- Changes in Prolactin and Insulin Resistance in PCOS Patients Undergoing Metformin Treatment: A Retrospective Study
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Optimized polycystic ovarian disease prognosis and classification using AI based computational approaches on multi-modality data
- 105 Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Genital Arousal Disorder
- THE MULTIFACETED APPROACH TO POLYCYSTIC OVARIAN SYNDROME: A REVIEW OF TRADITIONAL AND ALLOPATHIC MEDICINE
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Sexual Arousal Disorder
- Case 33-2015
- FASCE, benefit of spironolactone for treating acne of adult female: study protocol for a randomized double-blind trial
- Hyperandrogenemia in an ethnically heterogeneous cohort of Midwestern United States diabetic gestations
- Polycystic ovarian syndrome: current understanding of pathogenesis, diagnosis and treatment
- Spironolactone therapy for hyperandrogenic anovulatory women--clinical and endocrinological study.
- (798) Finasteride 1 mg: Silent Impacts on Male Fertility Despite Preserved Hormonal Balance
- Modern approaches to diagnostics of hyperandrogenism distributed forms in reproductive aged women
- Practical approaches to the use of markers of biochemical hyperandrogenism in women
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
- The Value of Androgen Measures for Diagnosing Polycystic Ovary Syndrome (PCOS) in an Unselected Population
- Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
- Polycystic Ovary Syndrome (PCOS) Presenting with Delayed Menarche and Clitoromegaly
- Validation and Reference Ranges of Hair Cortisol Measurement in Healthy Children
- Disorders of ovulation
- Androgens and Antiandrogens
- Lack of association between clinical and biochemical hyperandrogenism in patients with polycystic ovary syndrome
- In vivo and in vitro exposure to free fatty acids induce increased androgen production in animal models: a potential pathogenic factor of the polycystic ovary syndrome
- Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study<sup>1</sup>